Barrow Neurological Institute is the world's largest neurological disease treatment and research institution, and is consistently ranked as one of the best neurosurgical training centers in the United States. Founded in 1962, the main campus is located at 350 W. Thomas Road, Phoenix, Arizona.

During the past decade, Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center" #1 sponsor was "Acorda Therapeutics" with 5 trials, followed by "Neuraltus Pharmaceuticals, Inc." with 2 trials sponsored, "AC Immune SA" with 1 trials sponsored, "Cytokinetics" with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center" #1 collaborator was "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator, "Barrow Neurological Institute" with 1 trials as a collaborator, "LuMind IDSC Foundation" with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center" are "Multiple Sclerosis" (5 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Amyotrophic Lateral Sclerosis (ALS)" (1 trials), "Cervical Dystonia" (1 trials) and "Down Syndrome" (1 trials). Many other conditions were trialed in "Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center" in a lesser frequency.

Most popular intervention types in "Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center" are "Drug" (10 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Fampridine-SR" (4 trials), "ACI-24 high dose" (1 trials), "ACI-24 low dose" (1 trials) and "Botulinum toxin type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".